{"id":1762,"date":"2017-01-31T11:27:46","date_gmt":"2017-01-31T16:27:46","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=1762"},"modified":"2017-01-31T11:31:55","modified_gmt":"2017-01-31T16:31:55","slug":"january-2017-ipo-track-record-recap","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/january-2017-ipo-track-record-recap\/","title":{"rendered":"January 2017 IPO Track Record Recap"},"content":{"rendered":"<h3><a href=\"https:\/\/www.ipoboutique.com\/newsletter.htm\" target=\"_blank\">SUBSCRIBE TO IPOBoutique\u2019s Free Weekly Newsletter\u00a0<\/a><\/h3>\n<p>The IPO market came to \u00a0life after the MLK day holiday as seven deals priced raising a total of $2.1bn. Two deals priced above range and 1 priced below range. The average gain at first trade was 6.3% above the offering price. The first technology deal of 2017 was cancelled as AppDynamics was purchased at a premium two-days prior to its debut by Cisco. One deal that was scheduled to price in January, Visterra Therapeutics, has not priced and is currently in day-to-day status.<\/p>\n<p>Compared to 2016, the IPO market is well-ahead of pace. The first IPOs of 2016 did not come until February.<\/p>\n<p>This post will allow us to post our results and emphasize the value of IPOBoutique&#8217;s senior managing partner Scott Sweet&#8217;s ratings. You can check out\u00a0<strong>o<a href=\"https:\/\/www.ipoboutique.com\/cgi\/ipo-track-record-summary-report.php\" target=\"_blank\">ur entire track record at this link.<\/a><\/strong><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/01\/Screen-Shot-2017-01-31-at-11.28.52-AM.png\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter size-full wp-image-1765\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/01\/Screen-Shot-2017-01-31-at-11.28.52-AM.png\" alt=\"Screen Shot 2017-01-31 at 11.28.52 AM\" width=\"1162\" height=\"280\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/01\/Screen-Shot-2017-01-31-at-11.28.52-AM.png 1162w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/01\/Screen-Shot-2017-01-31-at-11.28.52-AM-600x145.png 600w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/01\/Screen-Shot-2017-01-31-at-11.28.52-AM-300x72.png 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/01\/Screen-Shot-2017-01-31-at-11.28.52-AM-1024x247.png 1024w\" sizes=\"(max-width: 1162px) 100vw, 1162px\" \/><\/a><\/p>\n<p><strong><span style=\"text-decoration: underline;\">Five-Rating<\/span><\/strong><\/p>\n<p>We consider these IPOs to be the best of the best. In our nine years of keeping a track-record we have given just 14 \u2018five-ratings\u2019 and all 14 have hit their respective targets. However, in January\u00a02017, we did not give a \u2018five\u2019 rating.<\/p>\n<p><strong><span style=\"text-decoration: underline;\">Four-Rating<\/span><\/strong><\/p>\n<p>We consider these IPOs to be very strong buys and we anticipate 1-to-2 points of premium or higher in the first week of trading. \u00a0In January 2017, we did not give a \u2018four\u2019 rating.<\/p>\n<p><strong><span style=\"text-decoration: underline;\">Three-Rating\u00a0<\/span><\/strong><\/p>\n<p>We consider these IPOs to be moderate buys and we anticipate 1\/2 to 1 point premium or more likely in the cases of these new issues. This past month six deals debuted that we rated as a &#8216;three&#8217; with an average return $1.85 above the offering price at first trade &#8212; or, in terms of percentage, 9.3%. The best deal of the month was <strong>REV Group (NYSE: REVG)<\/strong> which priced $1.00 above the range and opened with a $3.75 premium at first trade. The largest deal in January, <strong>JELD-WEN Holding (NYSE: JELD)<\/strong>, who raised $575m, faired well as the high-end priced deal netted a premium\u00a0of $2.25 at first trade. Other deals we rated as a &#8216;three&#8217; were <strong>Keane Group (NYSE: FRAC)<\/strong>, <strong>Jounce Therapeutics (Nasdaq: JNCE)<\/strong>, <strong>AnaptysBio (Nasdaq: ANAB)<\/strong> and <strong>Jagged Peak Energy (NYSE: JAG)<\/strong>.<\/p>\n<p><strong><span style=\"text-decoration: underline;\">Two-Rating<\/span><\/strong><\/p>\n<p>We consider these IPOs to be \u201cneutral\u201d and thus do not have a particular point threshold to hit in order for us to deem it as \u2018hitting its target\u2019. We gave one deal a &#8216;two-rating&#8217;, <strong>ObsEva (Nasdaq: OBSV)<\/strong>, and that deal opened $1.71 below a mid-range pricing of $15.00.<\/p>\n<p><strong><span style=\"text-decoration: underline;\">One-Rating<\/span><\/strong><\/p>\n<p>We advise our subscribers to avoid these IPOs as we consider them to be risky. In our nine years of keeping a track-record we have given just 49 \u2018one\u2019 ratings. In January, we did not give a \u2018one\u2019 rating.<\/p>\n<p>IPOBoutique.Com provides comprehensive research, ratings and daily advisories on new issues hitting the IPO market. To subscribe to IPOBoutique&#8217;s service:\u00a0<a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">click here.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>SUBSCRIBE TO IPOBoutique\u2019s Free Weekly Newsletter\u00a0 The IPO market came to \u00a0life after the MLK day holiday as seven deals priced raising a total of $2.1bn. Two deals priced above range and 1 priced below range. The average gain at first trade was 6.3% above the offering price. The first technology deal of 2017 was[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,165],"tags":[1016,1018,1032],"class_list":["post-1762","post","type-post","status-publish","format-standard","hentry","category-ipo","category-monthly-recap","tag-jeld","tag-obsv","tag-revg"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1762","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=1762"}],"version-history":[{"count":4,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1762\/revisions"}],"predecessor-version":[{"id":1767,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1762\/revisions\/1767"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=1762"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=1762"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=1762"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}